tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Sophia Genetics raises FY25 revenue view to $75M-$77M from $72M-$76M

Consensus is $74.52M. Adjusted EBITDA loss is now expected to be between $39 and $41 million, which includes the impact of the Swiss social charges on equity-based compensation as well as the appreciation of the Swiss Franc relative to the U.S. Dollar and its impact on its costs.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1